Neuroimaging and the Investigation of Drug-Drug Interactions Involving Psychedelics.
Neurosci Insights October 8, 2024 Matthew B Wall, Rebecca Harding, Natalie Ertl et al. 3 citations
Psychedelic therapies are new psychiatric treatments that may need to be combined with existing medications, but little is known about their interactions with common psychiatric drugs. This commentary reviews key findings on such drug-drug interactions and proposes that multimodal neuroimaging, combining PET and fMRI with other measures, offers the most thorough way to study these interactions across molecular, functional, and clinical levels.